Annual accounts
Audit Exemption Subsidiary accounts
31/12/2026Filing deadline
- Next accounts made up to
- 31/12/2025
- Last accounts made up to
- 31/12/2024
Reference data exactly as held at Companies House.
The 4 most recent documents filed at Companies House.
Memorandum and Articles of Association
Resolutions
Termination of appointment of Murray Ellender as a director on 2026-02-26
Consolidated accounts of parent company for subsidiary company period ending 31/12/24
What Pre-Score will tell you

The two filings Companies House requires every year, and where each one stands against its deadline today.
Audit Exemption Subsidiary accounts
31/12/2026Filing deadline
Confirms the registry record is up to date
10/12/2026Filing deadline
The latest figures ECONSULT HEALTH LIMITED filed. Okredo holds filed accounts data for 2021–2024; the year-by-year record is on the financials page.
Net Assets
2023: £4.43M
Total Assets
2023: £12.46M
Cash in Bank
2023: £3.63M
Total Liabilities
2023: £7.82M
Employees
2023: 87
Of the 4 measures with an earlier filing to compare against, 4 fell. Total assets moved furthest, down 66.73% on 2023. See the full financial analysis for ECONSULT HEALTH LIMITED.
The full financial record
Four ways through ECONSULT HEALTH LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Headcount as reported to Companies House for 2021–2024.
| Year | Employees | Change |
|---|---|---|
| 2024 | 72 | -15 |
| 2023 | 87 | -5 |
| 2022 | 92 | +34 |
| 2021 | 58 | – |
Reported employee count increased from 58 in 2021 to 72 in 2024. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 10/05/2011–01/12/2015 | 7 | |
| Director | 17/11/2021–16/09/2024 | 7 | |
| Director | 14/05/2019–13/11/2019 | 22 | |
| Director | 17/06/2016–17/11/2021 | 6 | |
| Director | 10/11/2022–16/09/2024 | 53 | |
| Director | 14/05/2019–13/03/2023 | 2 | |
| Director | 13/02/2025–26/02/2026 | 8 | |
| Director | 17/06/2016–10/11/2022 | 44 | |
| Director | 17/03/2021–31/05/2024 | 5 | |
| Director | 06/10/2020–29/09/2022 | 7 | |
| Secretary | 14/05/2019–13/11/2019 | 0 | |
| Director | 11/05/2011–15/02/2012 | 5 | |
| Director | 01/01/2017–13/03/2023 | 17 | |
| Director | 08/09/2022–16/09/2024 | 6 | |
| Director | 05/04/2022–16/09/2024 | 1 | |
| Director | 10/05/2011–16/09/2024 | 8 | |
| Director | 01/09/2021–13/03/2023 | 9 | |
| Director | 16/09/2024–Present | 15 | |
| Director | 10/05/2011–08/01/2018 | 7 |
Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 16/09/2024–16/09/2024 | 15 | |
| 11/05/2020–16/09/2024 | 2 | |
| 11/05/2020–Present | 2 | |
| 06/04/2016–10/05/2020 | 0 | |
| 22/03/2017–22/03/2017 | 0 | |
| 16/09/2024–Present | 15 | |
| 16/09/2024–Present | 2 |
Every document on the Companies House record, newest first.
Memorandum and Articles of Association
Resolutions
Termination of appointment of Murray Ellender as a director on 2026-02-26
Consolidated accounts of parent company for subsidiary company period ending 31/12/24
Notice of agreement to exemption from audit of accounts for period ending 31/12/24
Audit exemption subsidiary accounts made up to 2024-12-31
Audit exemption statement of guarantee by parent company for period ending 31/12/24
Confirmation statement made on 2025-11-26 with updates
Cessation of Danoosh Vahdat as a person with significant control on 2024-09-16
Notification of Huma Therapeutics Limited as a person with significant control on 2024-09-16
Appointment of Dr Murray Ellender as a director on 2025-02-13
Compulsory strike-off action has been discontinued
Showing 12 of 40 filings
See when the next accounts and confirmation statement are due
88 UK companies are similar to ECONSULT HEALTH LIMITED, sharing the same company status (Active), the same industry sector and activity group (Business and domestic software development) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
2 Jubilee Place, London SW3 3TQ
37 Commercial Road, Poole, England BH14 0HU
Sherwood House 7 Gregory, Boulevard,, Nottingham NG7 6LB
1 Mark Square, 4th Floor, London EC2A 4EG
6th Floor 2 London Wall Place, London EC2Y 5AU
A short description of the company, written from its Companies House record.
ECONSULT HEALTH LIMITED is a private limited company registered in the United Kingdom, based in 13th Floor, 21-24 Millbank Tower Millbank, London SW1P 4QP. Companies House classifies its business as Business and domestic software development, one of 2 SIC classifications on its record. It has been on the register for 15 years 4 months.
The register currently records it as active. Its 2024 accounts report net assets of £-2.73M and 72 employees.
Answered from this company's own registry record and filed figures.
Companies House records ECONSULT HEALTH LIMITED under 2 registered business activities: Business and domestic software development (62.01/2 - SIC 2007) and General medical practice activities (86.21 - SIC 2007).
ECONSULT HEALTH LIMITED is recorded as active on the Companies House register, and has been on it since 10/05/2011.
The most recent accounts Okredo holds cover 2024 and report net assets of £-2.73M, total assets of £4.15M, cash in bank of £896.33K and total liabilities of £6.85M.
The most recent document on the record is dated 08/04/2026: Memorandum and Articles of Association, 5 months ago.
On the current registry record, accounts are due by 31/12/2026 and the next confirmation statement is due by 10/12/2026.
Companies House lists 19 officers (1 currently in post) and 7 people with significant control (3 current).